Immunocore Holdings (IMCR) Non-cash Items (2021 - 2022)
Immunocore Holdings (IMCR) posted quarterly Non-cash Items of $1.6 million for Q4 2022, up 1033.52% year-on-year from $143211.4 in Q4 2021, and up 966.29% on a QoQ basis from -$187389.2 in Q3 2022.
Immunocore Holdings (IMCR) Non-cash Items (2021 - 2022) Analysis & Trends
Immunocore Holdings (IMCR) has reported Non-cash Items for 2 consecutive years, with $1.6 million the latest figure, recorded in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Immunocore Holdings | 1.72 Bn | 878.48 Mn | 106.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 1.62 Mn |
| Dec 31, 2022 | 1.62 Mn |
| Sep 30, 2022 | -187,389.18 |
| Sep 30, 2022 | -187,389.18 |
| Dec 31, 2021 | -173,893.37 |
| Dec 31, 2021 | -173,893.37 |